Table 1 Clinical and pathological information of 130 HCC patients included in TMAs.

From: WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression

Variable No. of patients P value
Age (years)   0.5741
<60 94  
≥60 36  
Sex   0.9238
Male 105  
Female 25  
Pathology Grade   <0.0001*
I 21  
II 73  
III 34  
TNM Stage   0.8736
1 10  
2 55  
3 56